Kiadis Pharma announces formation of renowned Scientific Advisory Board
October 22, 2019 01:00 ET
|
Kiadis Pharma N.V.
Amsterdam, The Netherlands, 22 October 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces...
Kiadis Pharma provides regulatory update on ATIR101
October 17, 2019 11:50 ET
|
Kiadis Pharma N.V.
Kiadis no longer expects EU conditional marketing authorization for ATIR101 in 2020Kiadis plans to refile at the conclusion of the ongoing phase 3 trial Amsterdam, The Netherlands, 17 October 2019 –...
Kiadis Pharma announces results for the six months ended June 30, 2019
September 10, 2019 01:00 ET
|
Kiadis Pharma N.V.
Kiadis to hold conference call with investors today at 15:00 CEST Amsterdam, The Netherlands, September 10, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and...
Kiadis Pharma Announces Investor Events for September 2019
August 19, 2019 11:45 ET
|
Kiadis Pharma N.V.
Company announces Notice of Results for the six months ended June 30, 2019 Amsterdam, The Netherlands, August 19, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam...
Kiadis Pharma to present at upcoming conference in August 2019
July 31, 2019 11:45 ET
|
Kiadis Pharma N.V.
Kiadis Pharma to present at upcoming conference in August 2019 Amsterdam, The Netherlands, July 31, 2019 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels:...
Kiadis Pharma Announces Results Annual General Meeting
June 24, 2019 11:50 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma Announces Results Annual General Meeting Amsterdam, The Netherlands, June 24, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels:...
Kiadis Pharma completes acquisition of CytoSen Therapeutics, Inc.
June 06, 2019 01:30 ET
|
Kiadis Pharma Netherlands B.V.
Amsterdam, The Netherlands, June 6, 2019 - Kiadis Pharma N.V. ("Kiadis" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it...
Kiadis Pharma to present at upcoming conferences in June 2019
June 03, 2019 11:45 ET
|
Kiadis Pharma Netherlands B.V.
Kiadis Pharma to present at upcoming conferences in June 2019 Amsterdam, The Netherlands, June 3, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or...
Kiadis Pharma raises c.EUR 28 million in a private placement of c.3.7 million new shares
May 31, 2019 02:00 ET
|
Kiadis Pharma Netherlands B.V.
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...
Kiadis Pharma launches a private placement of new shares to raise approximately EUR 25 million
May 30, 2019 11:45 ET
|
Kiadis Pharma Netherlands B.V.
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release,...